Pascalis Vergidis, MD
@pascalisid.bsky.social
Infectious Disease physician | Associate Professor at Mayo Clinic | Microbiology Course Director | ABIM Governance Member
Department of Medicine Staff Awards @mayocliniccancer.bsky.social
Honored to be a Member of the amazing CAR-T cell therapy team.
Honored to be a Member of the amazing CAR-T cell therapy team.
January 24, 2026 at 1:21 PM
Department of Medicine Staff Awards @mayocliniccancer.bsky.social
Honored to be a Member of the amazing CAR-T cell therapy team.
Honored to be a Member of the amazing CAR-T cell therapy team.
Mycology Lab for the medical students at Mayo Clinic Alix School of Medicine. We reviewed morphological differences between Aspergillus and Mucorales.
January 23, 2026 at 1:39 AM
Mycology Lab for the medical students at Mayo Clinic Alix School of Medicine. We reviewed morphological differences between Aspergillus and Mucorales.
Included in this year’s Mycology Lecture for the medical students at Mayo Clinic Alix School of Medicine.
Trichophyton indotinae, an emerging fungal threat
Trichophyton indotinae, an emerging fungal threat
January 22, 2026 at 12:28 AM
Included in this year’s Mycology Lecture for the medical students at Mayo Clinic Alix School of Medicine.
Trichophyton indotinae, an emerging fungal threat
Trichophyton indotinae, an emerging fungal threat
Microbiology course at Mayo Clinic Alix School of Medicine. We reviewed 4 case of tuberculosis with a focus on social determinants of health.
Excellent discussion led by our social worker, Mariah Thompson, and Dr. Zami Temesgen, principal investigator Mayo Clinic Center for Tuberculosis.
Excellent discussion led by our social worker, Mariah Thompson, and Dr. Zami Temesgen, principal investigator Mayo Clinic Center for Tuberculosis.
January 17, 2026 at 1:57 AM
Microbiology course at Mayo Clinic Alix School of Medicine. We reviewed 4 case of tuberculosis with a focus on social determinants of health.
Excellent discussion led by our social worker, Mariah Thompson, and Dr. Zami Temesgen, principal investigator Mayo Clinic Center for Tuberculosis.
Excellent discussion led by our social worker, Mariah Thompson, and Dr. Zami Temesgen, principal investigator Mayo Clinic Center for Tuberculosis.
Bacteriology Lab for the medical students at Mayo Clinic Alix School of Medicine led by Dr. Bobbi Pritt.
We had 12 stations. All about Gram stains and cultures! Note the green metallic sheen of E. coli on Eosin Methylene Blue (EMB) agar.
We had 12 stations. All about Gram stains and cultures! Note the green metallic sheen of E. coli on Eosin Methylene Blue (EMB) agar.
January 14, 2026 at 4:37 PM
Bacteriology Lab for the medical students at Mayo Clinic Alix School of Medicine led by Dr. Bobbi Pritt.
We had 12 stations. All about Gram stains and cultures! Note the green metallic sheen of E. coli on Eosin Methylene Blue (EMB) agar.
We had 12 stations. All about Gram stains and cultures! Note the green metallic sheen of E. coli on Eosin Methylene Blue (EMB) agar.
Introduction to Microbiology for the medical students at the Mayo Clinic Alix School of Medicine
We discussed this MMWR publication which brought us back to the onset of the #HIV epidemic.
We discussed this MMWR publication which brought us back to the onset of the #HIV epidemic.
January 12, 2026 at 10:54 PM
Introduction to Microbiology for the medical students at the Mayo Clinic Alix School of Medicine
We discussed this MMWR publication which brought us back to the onset of the #HIV epidemic.
We discussed this MMWR publication which brought us back to the onset of the #HIV epidemic.
Looking forward to our journal club #MayoClinic Infectious Disease Fellowship. Adjunctive corticosteroids in hypoxemic patients with non-HIV Pneumocystis pneumonia. No difference in 28-day mortality. However, need for mechanical ventilation was lower in the steroid group.
December 6, 2025 at 2:04 PM
Looking forward to our journal club #MayoClinic Infectious Disease Fellowship. Adjunctive corticosteroids in hypoxemic patients with non-HIV Pneumocystis pneumonia. No difference in 28-day mortality. However, need for mechanical ventilation was lower in the steroid group.
As a member of the ABIM Infectious Disease Approval Committee, I would like to congratulate those who recently passed their Boards. You are all committed to delivering exceptional patient care and upholding the highest standards in Medicine.
December 5, 2025 at 6:50 PM
As a member of the ABIM Infectious Disease Approval Committee, I would like to congratulate those who recently passed their Boards. You are all committed to delivering exceptional patient care and upholding the highest standards in Medicine.
Reposted by Pascalis Vergidis, MD
How best to treat invasive aspergillosis? @pascalisid.bsky.social reviewing key clinical studies informing this choice - important to monitor vori levels , NB: AmB @idweek.bsky.social #IDWeek2025 #TxID #IDSky
October 20, 2025 at 12:33 PM
How best to treat invasive aspergillosis? @pascalisid.bsky.social reviewing key clinical studies informing this choice - important to monitor vori levels , NB: AmB @idweek.bsky.social #IDWeek2025 #TxID #IDSky
Please join us this Monday 8-9 am at IDWeek. Difficult-to-treat mold infections. Dimitrios Farmakiotis will be discussing treatment of mucormycosis. I will be discussing aspergillosis.
October 18, 2025 at 5:13 PM
Please join us this Monday 8-9 am at IDWeek. Difficult-to-treat mold infections. Dimitrios Farmakiotis will be discussing treatment of mucormycosis. I will be discussing aspergillosis.
Reposted by Pascalis Vergidis, MD
There’s now an app for all things fungi 🦠🍄
Dr. Matthew Pullen, Assistant Professor at the University of Minnesota, helped launch Dr Fungus—a free app that brings the trusted resource to your phone.
Explore fungal infections, antifungal treatments, and case-based learning—all in one place.
Dr. Matthew Pullen, Assistant Professor at the University of Minnesota, helped launch Dr Fungus—a free app that brings the trusted resource to your phone.
Explore fungal infections, antifungal treatments, and case-based learning—all in one place.
Home - Doctor Fungus
Welcome to Doctor Fungus! An Educational Website of theMycoses Study Group Education and Research Consortium (MSGERC) [View Legal Information] Where to Start Mycology Case of the Month An Introducti...
DrFungus.org
October 7, 2025 at 1:09 PM
There’s now an app for all things fungi 🦠🍄
Dr. Matthew Pullen, Assistant Professor at the University of Minnesota, helped launch Dr Fungus—a free app that brings the trusted resource to your phone.
Explore fungal infections, antifungal treatments, and case-based learning—all in one place.
Dr. Matthew Pullen, Assistant Professor at the University of Minnesota, helped launch Dr Fungus—a free app that brings the trusted resource to your phone.
Explore fungal infections, antifungal treatments, and case-based learning—all in one place.
Reposted by Pascalis Vergidis, MD
🆕 MMWR: In NYC, NDM-CRE just surpassed KPC-CRE for the first time.
And nearly 75% of these cases had no long-term care facility link
This is a changing landscape of antibiotic resistance - happening across US
#IDSky
📄: www.cdc.gov/mmwr/volumes...
And nearly 75% of these cases had no long-term care facility link
This is a changing landscape of antibiotic resistance - happening across US
#IDSky
📄: www.cdc.gov/mmwr/volumes...
July 10, 2025 at 5:10 PM
🆕 MMWR: In NYC, NDM-CRE just surpassed KPC-CRE for the first time.
And nearly 75% of these cases had no long-term care facility link
This is a changing landscape of antibiotic resistance - happening across US
#IDSky
📄: www.cdc.gov/mmwr/volumes...
And nearly 75% of these cases had no long-term care facility link
This is a changing landscape of antibiotic resistance - happening across US
#IDSky
📄: www.cdc.gov/mmwr/volumes...
Reposted by Pascalis Vergidis, MD
Detection of Mucorales antigen in BAL samples using a newly developed lateral-flow device
A Mucorales antigen test is sorely needed
This one had Sn of 76.92%, Sp of 75.51%, respectively, PPV 45.45%, and a NPV 92.5% (Not good enough but could augment qPCR)
journals.asm.org/doi/10.1128/...
A Mucorales antigen test is sorely needed
This one had Sn of 76.92%, Sp of 75.51%, respectively, PPV 45.45%, and a NPV 92.5% (Not good enough but could augment qPCR)
journals.asm.org/doi/10.1128/...
June 20, 2025 at 7:27 PM
Detection of Mucorales antigen in BAL samples using a newly developed lateral-flow device
A Mucorales antigen test is sorely needed
This one had Sn of 76.92%, Sp of 75.51%, respectively, PPV 45.45%, and a NPV 92.5% (Not good enough but could augment qPCR)
journals.asm.org/doi/10.1128/...
A Mucorales antigen test is sorely needed
This one had Sn of 76.92%, Sp of 75.51%, respectively, PPV 45.45%, and a NPV 92.5% (Not good enough but could augment qPCR)
journals.asm.org/doi/10.1128/...
Join us for a panel discussion on “Leveraging Partnerships to Fight Fungal Diseases” June 19
2.55-3.25 pm @ASMicrobiology
Dallas Smith @CDCgov
Sean Zhang, Fungal Diagnostics Laboratory Consortium
Rob Purdie, MYCology Advocacy, Research & Education
Zachary Rubin @lapublichealth
Me @MSG_ERC
2.55-3.25 pm @ASMicrobiology
Dallas Smith @CDCgov
Sean Zhang, Fungal Diagnostics Laboratory Consortium
Rob Purdie, MYCology Advocacy, Research & Education
Zachary Rubin @lapublichealth
Me @MSG_ERC
June 13, 2025 at 5:20 PM
Join us for a panel discussion on “Leveraging Partnerships to Fight Fungal Diseases” June 19
2.55-3.25 pm @ASMicrobiology
Dallas Smith @CDCgov
Sean Zhang, Fungal Diagnostics Laboratory Consortium
Rob Purdie, MYCology Advocacy, Research & Education
Zachary Rubin @lapublichealth
Me @MSG_ERC
2.55-3.25 pm @ASMicrobiology
Dallas Smith @CDCgov
Sean Zhang, Fungal Diagnostics Laboratory Consortium
Rob Purdie, MYCology Advocacy, Research & Education
Zachary Rubin @lapublichealth
Me @MSG_ERC
Visited the historic city of Philadelphia to attend the American Board of Internal Medicine (ABIM) New Governance Orientation. Looking forward to serving on the Infectious Disease Approval Committee.
Of the profession, for the public
Of the profession, for the public
June 12, 2025 at 2:04 PM
Visited the historic city of Philadelphia to attend the American Board of Internal Medicine (ABIM) New Governance Orientation. Looking forward to serving on the Infectious Disease Approval Committee.
Of the profession, for the public
Of the profession, for the public
Synthesis of the available literature on the use of CMV-specific T-cell therapy in adult and pediatric HSCT and SOT recipients.
Several patients on concurrent antivirals, which confounded the effectiveness of VSTs
@CIDJournal @transplantidnet.bsky.social
academic.oup.com/cid/advance-...
Several patients on concurrent antivirals, which confounded the effectiveness of VSTs
@CIDJournal @transplantidnet.bsky.social
academic.oup.com/cid/advance-...
Virus-Specific T-Cell Therapy for Prophylaxis and Treatment of Cytomegalovirus Infections After Transplantation: a Scoping Review
Cytomegalovirus-specific T cells have been used in studies of primarily adult hematopoietic stem cell transplant recipients. Heterogenous trial design and
academic.oup.com
June 8, 2025 at 11:24 AM
Synthesis of the available literature on the use of CMV-specific T-cell therapy in adult and pediatric HSCT and SOT recipients.
Several patients on concurrent antivirals, which confounded the effectiveness of VSTs
@CIDJournal @transplantidnet.bsky.social
academic.oup.com/cid/advance-...
Several patients on concurrent antivirals, which confounded the effectiveness of VSTs
@CIDJournal @transplantidnet.bsky.social
academic.oup.com/cid/advance-...
Dr. Jeniel Nett discussing biofilm at the 2025 Scientific Meeting on Candida auris @msgerc.bsky.social
June 6, 2025 at 7:52 PM
Dr. Jeniel Nett discussing biofilm at the 2025 Scientific Meeting on Candida auris @msgerc.bsky.social
High Kaposi sarcoma-associated herpesvirus seroprevalence in donors and recipients with HIV, particularly among MSM. Reassuringly, disease was rare.
@transplantidnet.bsky.social
academic.oup.com/cid/advance-...
@transplantidnet.bsky.social
academic.oup.com/cid/advance-...
Kaposi Sarcoma–Associated Herpesvirus Risk and Disease in Kidney Donors and Transplant Recipients With Human Immunodeficiency Virus in the United States
The prevalence of Kaposi sarcoma–associated herpesvirus (KSHV) was high among kidney donor and transplant recipients with HIV. Posttransplant KSHV-associat
academic.oup.com
June 6, 2025 at 1:10 PM
High Kaposi sarcoma-associated herpesvirus seroprevalence in donors and recipients with HIV, particularly among MSM. Reassuringly, disease was rare.
@transplantidnet.bsky.social
academic.oup.com/cid/advance-...
@transplantidnet.bsky.social
academic.oup.com/cid/advance-...
In a phase 3 clinical trial, pemivibart provided prophylactic efficacy against COVID-19 in immunocompromised patients and individuals at risk for exposure. Four of 623 participants experienced anaphylactic reactions @transplantidnet.bsky.social
academic.oup.com/cid/advance-...
academic.oup.com/cid/advance-...
Safety and Efficacy of Pemivibart, a Long-Acting Monoclonal Antibody, for Prevention of Symptomatic COVID-19: Interim Results From a Phase 3 Randomized Clinical Trial (CANOPY)
AbstractBackground. We report an interim analysis of safety and efficacy of pemivibart in individuals with (cohort A) or without (cohort B) significant imm
academic.oup.com
June 2, 2025 at 9:08 PM
In a phase 3 clinical trial, pemivibart provided prophylactic efficacy against COVID-19 in immunocompromised patients and individuals at risk for exposure. Four of 623 participants experienced anaphylactic reactions @transplantidnet.bsky.social
academic.oup.com/cid/advance-...
academic.oup.com/cid/advance-...
Reposted by Pascalis Vergidis, MD
Increasing Fluconazole Resistance in Candida parapsilosis: A 10-Year Analysis of Blood Culture Isolates at a US Reference Laboratory (2015–2024)
Fluco-R C parapsilosis ⬆️ from 8.2% to 20.3% in BCx isolates tested @ Mayo
Jack McHugh ... @pascalisid.bsky.social
academic.oup.com/jid/advance-...
Fluco-R C parapsilosis ⬆️ from 8.2% to 20.3% in BCx isolates tested @ Mayo
Jack McHugh ... @pascalisid.bsky.social
academic.oup.com/jid/advance-...
May 15, 2025 at 3:54 PM
Increasing Fluconazole Resistance in Candida parapsilosis: A 10-Year Analysis of Blood Culture Isolates at a US Reference Laboratory (2015–2024)
Fluco-R C parapsilosis ⬆️ from 8.2% to 20.3% in BCx isolates tested @ Mayo
Jack McHugh ... @pascalisid.bsky.social
academic.oup.com/jid/advance-...
Fluco-R C parapsilosis ⬆️ from 8.2% to 20.3% in BCx isolates tested @ Mayo
Jack McHugh ... @pascalisid.bsky.social
academic.oup.com/jid/advance-...
Reposted by Pascalis Vergidis, MD
Silence=Death Redux: Infectious Diseases, Public Health, and the Imperative to Resist
✅ Just Accepted
✍️ @ericmeyerowitz.bsky.social @germhuntermd.bsky.social
#IDSky
✅ Just Accepted
✍️ @ericmeyerowitz.bsky.social @germhuntermd.bsky.social
#IDSky
Silence=Death Redux: Infectious Diseases, Public Health, and the Imperative to Resist
In this perspective, we recount the early executive actions that impact every aspect of the field infectious diseases.
doi.org
March 31, 2025 at 7:28 PM
ID Grand Rounds.
I discussed the following:
- ONE Health
- Aspergillus urine antigen
- Giant magnetoresistance-enabled PCR
- Rezafungin for prevention in bone marrow transplant
- Ibrexafungerp (FURI)
- Olorofim (Study 32)
- Our experience with fosmanogepix
I discussed the following:
- ONE Health
- Aspergillus urine antigen
- Giant magnetoresistance-enabled PCR
- Rezafungin for prevention in bone marrow transplant
- Ibrexafungerp (FURI)
- Olorofim (Study 32)
- Our experience with fosmanogepix
March 23, 2025 at 2:40 PM
ID Grand Rounds.
I discussed the following:
- ONE Health
- Aspergillus urine antigen
- Giant magnetoresistance-enabled PCR
- Rezafungin for prevention in bone marrow transplant
- Ibrexafungerp (FURI)
- Olorofim (Study 32)
- Our experience with fosmanogepix
I discussed the following:
- ONE Health
- Aspergillus urine antigen
- Giant magnetoresistance-enabled PCR
- Rezafungin for prevention in bone marrow transplant
- Ibrexafungerp (FURI)
- Olorofim (Study 32)
- Our experience with fosmanogepix
In rare cases, vaping-associated lung injury (EVALI) may lead to irreversible damage requiring lung transplantation
March 13, 2025 at 11:48 AM
In rare cases, vaping-associated lung injury (EVALI) may lead to irreversible damage requiring lung transplantation
Can filgrastim precipitate organ rejection ?
March 12, 2025 at 2:55 PM
Can filgrastim precipitate organ rejection ?
We used Giant Magnetoresistance to diagnose invasive fungal infection. The assay has the potential to detect trace amounts of fungal DNA in serum
academic.oup.com/ofid/article...
academic.oup.com/ofid/article...
A Novel Giant Magnetoresistance–Enabled Multiplex Polymerase Chain Reaction Assay for the Diagnosis of Invasive Fungal Infection
AbstractBackground. Despite advances in clinical microbiology, the diagnosis of invasive fungal infections remains challenging. Giant magnetoresistance (GM
academic.oup.com
February 27, 2025 at 5:01 PM
We used Giant Magnetoresistance to diagnose invasive fungal infection. The assay has the potential to detect trace amounts of fungal DNA in serum
academic.oup.com/ofid/article...
academic.oup.com/ofid/article...